ESMO 2021 - HER2-low breast cancer: evolution from primary breast cancer to relapse

Primary outcome analysis of invasive disease-free survival for monarchE a Quebec perspective

A Quebec clinical perspective of the randomized clinical trial SWOG S1007 (RxPonder)

Expected medium- and long-term impact of the COVID-19 on Breast Cancer Treatment in Quebec

SABCS 2020 - Circulating Tumor Cell Dynamics May Predict Treatment Response and Prognosis